Search

Harry P Selker

from Wellesley, MA
Age ~72
Get Report
Also known as:
Harry Dr Selker, Harry P Selkar, Harry P Selken
Phone and address:
155 Hampshire Rd, Wellesley, MA 02481
(781) 235-6535
Related to:
Arlene O Marro
Connected to:
Martina L Selker, 35Stephanie L Selker, 28Blaine A Selkie, 70Jane F Selking, 72Angela R Selkirk, 51Candace H Selkirk, 57Daniel F Selkirk, 85Joanne B Selkirk, 55Linda E Selkirk, 70Marc T Selkirk, 67

Harry Selker Phones & Addresses

  • 155 Hampshire Rd, Wellesley Hills, MA 02481 (781) 235-6535
  • 26 Pine Tree Rd, Wellesley, MA 02482 (401) 647-5705
  • 75 Newton St #E, Boston, MA 02118
  • Bedford, MA
  • Wellesley Hls, MA

Work

Company: Pratt Diagnostic Center Address: 750 Washington St, Boston, MA 02111 Phones: (617) 636-2800

Education

School / High School: The Warren Alpert Medical School Of Brown University 1978

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Internal Medicine, 1981

Specialities

Internal Medicine

Professional Records

Medicine Doctors

Harry Selker Photo 1

Dr. Harry P Selker, Boston MA - MD (Doctor of Medicine)

View page
Specialties:
Internal Medicine
Address:
Pratt Diagnostic Center
750 Washington St, Boston, MA 02111
(617) 636-2800 (Phone)

Pratt Diagnostic Center, Internal Medicine and Adult Primary Care
800 Washington St Suite 327, Boston, MA 02111
(617) 636-7695 (Phone), (617) 636-3080 (Fax)
Certifications:
Internal Medicine, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Pratt Diagnostic Center
750 Washington St, Boston, MA 02111

Pratt Diagnostic Center, Internal Medicine and Adult Primary Care
800 Washington St Suite 327, Boston, MA 02111

Tufts Medical Center
800 Washington Street, Boston, MA 02111
Education:
Medical School
The Warren Alpert Medical School Of Brown University
Graduated: 1978
Medical School
UCLA/Cedars Sinai Mc
Graduated: 1979
Medical School
Boston City Hospital
Graduated: 1981
Medical School
Boston University Mc
Graduated: 1982
Medical School
Rw Johnson Clin Scholar/UCLA
Graduated: 1984
Harry Selker Photo 2

Harry P. Selker

View page
Specialties:
Internal Medicine
Work:
Pratt Diagnostic Center
800 Washington St Proger 1 Bldg, Boston, MA 02111
(617) 636-2800 (phone), (617) 636-3080 (fax)
Education:
Medical School
Brown University Alpert Medical School
Graduated: 1978
Procedures:
Vaccine Administration
Conditions:
Atrial Fibrillation and Atrial Flutter
Attention Deficit Disorder (ADD)
Diabetes Mellitus (DM)
Disorders of Lipoid Metabolism
Erectile Dysfunction (ED)
Languages:
English
Description:
Dr. Selker graduated from the Brown University Alpert Medical School in 1978. He works in Boston, MA and specializes in Internal Medicine. Dr. Selker is affiliated with Tufts Medical Center.
Harry Selker Photo 3

Harry Paul Selker, Boston MA

View page
Specialties:
Internal Medicine
General Practice
Work:
Tufts Medical Center
800 Washington St, Boston, MA 02111
Tufts Medical Center
750 Washington St, Boston, MA 02111
Education:
Brown University (1978)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Harry Paul Selker
Harry Selker MD,MSPH
Internist
750 Washington St, Boston, MA 02111
(617) 636-7695
Harry Selker
Director
HEALTH RESOURCES IN ACTION, INC
Consulting Services And Develops Programs For A Wide Range Of Private And Public Sector Clients Concerning Health Issues. · Social & Educational Services · Social Services School/Educational Services · Internist
95 Berkeley St, Boston, MA 02116
95 Berkeley St 2, Boston, MA 02116
95 Berkley St, Boston, MA 02116
(617) 451-0049, (617) 536-5872, (617) 451-0062

Publications

Us Patents

Method Of Randomizing Patients In A Clinical Trial

View page
US Patent:
6450954, Sep 17, 2002
Filed:
Nov 1, 1999
Appl. No.:
09/431750
Inventors:
Harry P. Selker - Wellesley MA
Assignee:
New England Medical Center Hospitals, Inc. - Boston MA
International Classification:
A61B 500
US Classification:
600300, 128920, 128925, 205 3
Abstract:
A randomization mechanism for enabling randomization of a patient to one of two treatment options having different time-to-treatments is presented. Data is received for a patient experiencing symptoms of the type treatable by either of the two treatment options. The received data is used to compute for a first treatment option of the two treatment options at its associated time-to-treatment a benefit value. Assuming a benefit value for the second treatment option is an estimate of the computed first benefit value, the received data and computed benefit value are used to compute a maximum allowable delay time during which the benefit value for the second treatment option is no less than the benefit value computed for the first treatment option. When provided a given delay time by which the time-to-treatment of the second treatment option lags the first treatment option time-to-treatment, the mechanism determines if the given delay time is less than or equal to the allowable delay time. If the given delay time is determined to be less than or equal to the allowable delay time, then the patient is eligible for randomization.

Method For Predicting The Need For Dose Reductions In Chemotherapy For Patients With Breast Cancer: A Potential Decision Aid For The Use Of Myeloid Growth Factors

View page
US Patent:
20020037493, Mar 28, 2002
Filed:
Jun 25, 2001
Appl. No.:
09/891089
Inventors:
Panos Savvides - Boxford MA, US
Norma Terrin - Jamaica Plain MA, US
John Erban - Wakefield MA, US
Harry Selker - Wellesley MA, US
International Classification:
A01N001/00
US Classification:
435/001100
Abstract:
The invention provides provided a method and instrument for predicting the probability of a patient requiring a significant dose reduction in adjuvant chemotherapy for breast cancer and/or predicting whether early treatment with a myeloid growth factor is warranted, by determining the patient's dose-adjusted nadir absolute neutrophil count (ANC) in the first cycle of the chemotherapy schedule, further determining the patient's dose-adjusted percent change in platelet count from day one to the dose-adjusted nadir platelet count in the first cycle of the chemotherapy schedule, and then calculating the probability that the patient will receive a suboptimal chemotherapy dose using the dose-adjusted nadir ANC and dose-adjusted percent change in platelet count.

Adjustable Coefficients To Customize Predictive Instruments

View page
US Patent:
20030032871, Feb 13, 2003
Filed:
Jul 17, 2002
Appl. No.:
10/197091
Inventors:
Harry Selker - Wellesley MA, US
John Griffith - Natick MA, US
Assignee:
New England Medical Center Hospitals, Inc.
International Classification:
A61B005/00
US Classification:
600/301000
Abstract:
An apparatus for monitoring the medical condition of a patient, the apparatus including a medical instrument which during use monitors one or more clinical features of the patient; a predictive instrument arranged to receive output from the medical instrument and programmed to compute a probability of a medical outcome or diagnosis based on the monitored one or more clinical features, said predictive instrument further programmed to use a model to compute said probability, said model being characterized by a set of weights the values of which affect the computed probability; and an interface through which a user enters an input characterizing at least one of a physical setting in which the predictive instrument is to be used and a sub-population of patients on which the predictive instrument is to be used, wherein said characterizing input causes a corresponding one of a plurality of data sets to be used in said model to establish a value for one or more of said weights in said set of weights.

Computer-Assisted Multi-Dimensional Patient-Selection

View page
US Patent:
20040045560, Mar 11, 2004
Filed:
May 23, 2003
Appl. No.:
10/446264
Inventors:
David Kent - Cambridge MA, US
Robin Ruthazer - Newton MA, US
Harry Selker - Wellesley MA, US
Assignee:
New England Medical Center Hospitals, Inc.
International Classification:
A61B019/00
US Classification:
128/897000
Abstract:
An instrument for use with a patient who is experiencing acute ischemic stroke, the instrument for indicating whether to administer thrombolytic therapy to the patient after a predetermined elapsed time since onset of symptoms has passed, the instrument including an input device through which a user enters clinical information about the patient who is experiencing acute ischemic stroke; and a processor module programmed to use the entered clinical information to compute a predicted benefit to the health of the patient as a consequence of administering thrombolytic therapy to the patient at an onset to treatment time (OTT) that is greater than a predetermined time, the predicted benefit being derived from the entered clinical data.

Quality Improvement (Qi) Review System And Method

View page
US Patent:
20110184759, Jul 28, 2011
Filed:
Dec 21, 2010
Appl. No.:
12/974580
Inventors:
Harry P. Selker - Wellesley MA, US
Denise Daudelin - Hanover MA, US
Joni R. Beshansky - Wayland MA, US
Manlik Kwong - Corvallis OR, US
Assignee:
Clinical Care Systems, Inc. - Bedford MA
International Classification:
G06Q 50/00
US Classification:
705 3
Abstract:
A computer-implemented clinical quality review method involving: for each of a plurality of medical problem types, storing a corresponding set of review criteria; receiving a plurality of electronic patient care records (ePCRs) from a medical service provider (MSP), each ePCR identifying a patient treated by the MSP and information about the medical care provided to that patient by the MSP, including: clinical problem type, clinical impressions, symptoms, and details about the evaluation of and treatment provided to that patient by the MSP; and for each ePCR: (i) determining whether the medical care meets the set of review criteria associated with the medical problem type identified in that ePCR; (ii) if the medical care passes the set of review criteria, approving the medical care provided to that patient and forwarding information about the medical care provided to that patient to a reporting system; and (iii) if the medical care does not pass the set of review criteria, generating a notification indicating that a manual review of the medical care provided to that patient is required.

Cardiac Monitoring

View page
US Patent:
20120226120, Sep 6, 2012
Filed:
Oct 19, 2010
Appl. No.:
13/502264
Inventors:
Johanna Paola Contreras - Boston MA, US
Harry P. Selker - Wellesley MA, US
Assignee:
Tufts Medical Center, Inc. - Boston MA
International Classification:
A61B 5/0205
A61B 5/0402
A61N 1/00
A61B 5/1459
US Classification:
600325
Abstract:
A device for monitoring a heart includes a lead wire having a first end and a second end, the second end in contact with tissue of the heart; a first sensor disposed along the length of the lead wire; and a second sensor disposed at the second end of the lead wire. The first sensor is configured to measure an oxygen content of blood in the heart and the second sensor is configured to measure a fluid pressure in the heart. The device further includes a control module connected to the first end of the lead wire and configured to receive signals related to the measured fluid pressure and the measured oxygen content from the first and second sensors.

Continuous Monitoring Using A Predictive Instrument

View page
US Patent:
55012299, Mar 26, 1996
Filed:
Aug 1, 1994
Appl. No.:
8/283951
Inventors:
Harry P. Selker - Wellesley MA
John L. Griffith - Natick MA
Assignee:
New England Medical Center Hospital - Boston MA
International Classification:
A61B 504
US Classification:
128696
Abstract:
An instrument for continuously monitoring the condition of a patient who has a cardiovascular disease, the instrument including an electrocardiograph; a waveform analyzer which analyzes a current segment of an ECG waveform; a computer receiving output from the waveform analyzer; and a control module. The computer is programmed to complete a monitoring cycle in which the computer uses the output from the waveform analyzer to compute a probability of a life threatening cardiac condition based upon the current segment of the patient's ECG waveform. The control module causes the computer to periodically repeat the monitoring cycle and for each repetition of said monitoring cycle to compute a change-of-condition measure, wherein the change-of-condition measure is calculated by subtracting a computed probability for a previous monitoring cycle from the computed probability for the current monitoring cycle. The computer is also programmed to compare during each monitoring cycle the computed change-of-condition measure for that monitoring cycle to a threshold value and if in excess of the threshold value to generate an alarm notification.

Diagnostic Tool Using A Predictive Instrument

View page
US Patent:
60674660, May 23, 2000
Filed:
Nov 18, 1998
Appl. No.:
9/193971
Inventors:
Harry P. Selker - Wellesley MA
John L. Griffith - Natick MA
Joni R. Beshansky - Wayland MA
Assignee:
New England Medical Center Hospitals, Inc. - Boston MA
International Classification:
A61B 50402
US Classification:
600513
Abstract:
A method for evaluating a medical condition of a patient including the steps of monitoring one or more clinical features of a patient; based on the monitored features, computing a primary probability of a medical outcome or diagnosis; computing a plurality of conditional probabilities for a selected diagnostic test, the computed conditional probabilities including a first probability of the medical outcome or diagnosis assuming the selected diagnostic test produces a first outcome and a second probability of the medical outcome or diagnosis assuming the selected diagnostic test produces a second outcome; and displaying the computed primary probability as well as the plurality of computed conditional probabilities to a user as an aid to determining whether to administer the selected diagnostic test to the patient.

Isbn (Books And Publications)

Emergency Diagnostic Tests for Cardiac Ischemia: A Report from the National Heart Attack Alert Program (Nhaap) Coordinating Committee Working Group on Evaluation of Technologies for Identifying acu

View page
Author

Harry Selker

ISBN #

0632043040

Control profile
Harry P Selker from Wellesley, MA, age ~72 Get Report